Jericho Assisted Living
Saturday, March 18, 2017
ACC: Even Very Low Dose Rivaroxaban Prevents Recurrent VTE
(MedPage Today) -- Results from EINSTEIN CHOICE point to new clinical pathway
via
ACC: Even Very Low Dose Rivaroxaban Prevents Recurrent VTE
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment